Executive Summary
The IPO pipeline shows robust activity with 6 S-1 filings on March 13, 2026, dominated by SPACs (2/6), bank mutual-to-stock conversions (2/6), a microcap tech play, and a crypto ETF, highlighting diverse entry points into public markets amid limited traditional IPOs. No broad period-over-period financial trends available due to pre-IPO status, but common $10/share pricing in 4/6 filings signals standardized valuation approach for SPACs and banks versus Dravica's $0.03 outlier. Positive sentiment in CSB Financial contrasts with Dravica's negative going concern flag and JATT II's dilution risks, while neutrals dominate. Bank conversions emphasize depositor/plan priorities for subscription success, SPACs offer dry powder with 24-month windows, and niche plays like crypto staking add volatility. Portfolio implications favor monitoring bank conversions for stable liquidity events and SPACs for M&A catalysts, with cross-filing comparison revealing CSB's $14.55M proceeds potential outperforming Dravica's $120k micro-raise.
Tracking the trend? Catch up on the prior US IPO Pipeline SEC S-1 Filings digest from March 12, 2026.
Investment Signals(12)
- CSB Financial Inc.(BULLISH)▲
Positive sentiment on $9.35M-$14.55M IPO proceeds from 1.265M-1.455M shares at $10/share in mutual conversion, minimum 935k shares required, charitable foundation contribution signals community focus
- Rhinebeck Bancorp↓(BULLISH)▲
Neutral but material $33M offering (3.3M shares at $10/share) for 401(k) plan tied to MHC conversion, depositor purchase priorities enhance subscription likelihood vs. open market
- JATT II Acquisition Corp(BULLISH)▲
Mixed sentiment but $60M gross proceeds from 6M shares at $10/share plus $3M sponsor private placement commitment, non-binding $30M AI Biotech interest post-combination
- Voyager Acquisition Corp. II(BULLISH)▲
Neutral SPAC S-1 with prior drafts (Jan/Mar/Oct 2025) indicates advancing IPO readiness, CIK 2052096 blank check targeting acquisitions
- 21Shares Cronos ETF(BULLISH)▲
Neutral filing for CRO token ETF with staking model targeting [●]% utilization, quarterly cash distributions from rewards, Figment as provider adds operational credibility
- CSB Financial Inc.(BULLISH)▲
Incorporated Feb 2026 post-1889 bank charter, 2014 acquisition history shows operational continuity, outperforms Dravica's inception losses
- Rhinebeck Bancorp↓(BULLISH)▲
Continuous Rule 415 offering post-SEC approval, RBKB already Nasdaq-listed provides liquidity precedent vs. pure IPOs
- JATT II Acquisition Corp(BULLISH)▲
No warrants reduces complexity vs. typical SPACs, founder shares transferred to key execs/directors signals aligned incentives
- 21Shares Cronos ETF(BULLISH)▲
Name change from Jura Pentium (Mar 2025) and staking rewards sharing model differentiates from plain crypto trusts
- Voyager Acquisition Corp. II(BULLISH)▲
Multiple prior DRS filings demonstrate regulatory progress, 8/10 materiality flags timely SPAC opportunity
- Rhinebeck Bancorp↓(BULLISH)▲
Plan assets Dec 31, 2025 basis for sizing ensures realistic $33M raise vs. speculative microcaps
- CSB Financial Inc.(BULLISH)▲
Net proceeds $7.75M-$12.95M after expenses outperforms Dravica's $120k target by 100x scale
Risk Flags(10)
- Dravica Corporation/Going Concern[HIGH RISK]▼
Auditors flag substantial doubt, $12,384 net loss from Sep 2025 inception through Oct 31, 2025, no revenues, requires $30k minimum from $120k offering
- JATT II Acquisition Corp/Dilution[HIGH RISK]▼
1.725M founder shares acquired for $25k (par $0.0001) pose immediate material dilution to public holders vs. $60M IPO
- Dravica Corporation/Scale[HIGH RISK]▼
Self-underwritten 4M shares at $0.03 ($120k max) vs. peers at $10/share ($14M+), 100% president ownership raises governance concerns
- JATT II Acquisition Corp/Redemption[MEDIUM RISK]▼
Redemption rights capped at 20% aggregate without consent, tighter than typical SPACs increases de-SPAC execution risk
- Dravica Corporation/Financial Health[MEDIUM RISK]▼
Fiscal Oct 31 end, $8k prior private from president only, 270-day offering duration signals prolonged uncertainty
- Voyager Acquisition Corp. II/No Financials[MEDIUM RISK]▼
Blank check with no performance data or comparisons, prior drafts but unproven track record
- Rhinebeck Bancorp/Subscription Risk↓[MEDIUM RISK]▼
Purchase priorities favor depositors (>= $100 Dec 31, 2024) and 401(k), potential undersubscription if priorities unmet
- 21Shares Cronos ETF/Liquidity[MEDIUM RISK]▼
Staking up to [●]% CRO holdings with quarterly distributions uncertain/possibly zero if rewards insufficient
- JATT II Acquisition Corp/Mixed Sentiment[MEDIUM RISK]▼
Founder transfers (e.g., 150k to Dr. Sidhu) amid no warrants may deter traditional SPAC investors
- CSB Financial Inc/Extension Risk[LOW RISK]▼
Subscription expires June 2026 but extendable 90 days or to June 2028, delays conversion completion
Opportunities(10)
- CSB Financial Inc./Mutual Conversion(OPPORTUNITY)◆
Subscription offering June 2026 expiry with min 935k shares, positive sentiment and $12.95M net proceeds potential for bank growth
- JATT II Acquisition Corp/SPAC Dry Powder(OPPORTUNITY)◆
$60M + $3M sponsor for 24-month business combination window, $30M AI Biotech interest flags biotech target alpha
- Rhinebeck Bancorp/401(k) Liquidity↓(OPPORTUNITY)◆
$33M at $10/share post-conversion, Nasdaq RBKB precedent offers immediate trading vs. pure IPO lockups
- 21Shares Cronos ETF/Staking Yield(OPPORTUNITY)◆
Quarterly CRO staking rewards distributions, utilization [●]% targets yield play in crypto ecosystem vs. spot ETFs
- Voyager Acquisition Corp. II/SPAC Momentum(OPPORTUNITY)◆
Recent S-1 after 2025 drafts, blank check for acquisitions in maturing SPAC cycle
- CSB Financial Inc./Relative Scale(OPPORTUNITY)◆
$14.55M proceeds dwarfs Dravica's $120k, charitable 27.5k shares/$100k foundation enhances goodwill
- JATT II Acquisition Corp/No Warrants(OPPORTUNITY)◆
Simplified structure vs. peers reduces warrant dilution overhang, Cayman entity for flexibility
- Rhinebeck Bancorp/Depositor Priority↓(OPPORTUNITY)◆
Category 1 depositors first boosts subscription success rate vs. competitive retail IPOs
- 21Shares Cronos ETF/Differentiation(OPPORTUNITY)◆
Integrated staking with Figment, sponsor/custodian rewards model vs. non-yielding trusts
- Dravica Corporation/Turnaround(OPPORTUNITY)◆
Digital comm tools at $0.03/share, $30k min funds 12 months if subscribed, early-stage entry
Sector Themes(6)
- SPAC Standardization◆
2/6 filings (Voyager, JATT) at $10/share with 24-month windows, JATT's no-warrants and sponsor buys signal evolved terms reducing complexity [IMPLICATION: Lower dilution appeals to conservative investors]
- Bank MHC Conversions◆
2/6 (Rhinebeck $33M, CSB $14.5M max) prioritize depositors/401(k), positive/neutral sentiment, $10/share norm [IMPLICATION: High subscription success, liquidity events for regional banks]
- Micro/Niche Valuations◆
Dravica $0.03/share ($120k) vs. peers $10/share (50x gap), crypto ETF adds staking yield [IMPLICATION: Volatility alpha in outliers, scale favors banks/SPACs]
- Offering Timelines◆
All March 13, 2026 S-1s with CSB/Rhinebeck June 2026 expiries, JATT 24-months post-IPO [IMPLICATION: Near-term catalysts in conversions, longer SPAC M&A plays]
- Dilution Patterns◆
JATT founder 1.725M shares/$25k (high), Dravica 100% insider pre-IPO vs. diversified SPAC sponsors [IMPLICATION: Scrutinize pre-IPO ownership for post-listing pressure]
- Proceeds Spectrum◆
$60M (JATT) to $120k (Dravica), avg ~$18M, banks/SPACs dominate size [IMPLICATION: Capital access varies by structure, favor larger for stability]
Watch List(8)
- CSB Financial Inc./Subscription Expiry👁
Monitor June 2026 deadline +90-day extension or June 2028 completion for oversub/undersubscription signals
- JATT II Acquisition Corp/Business Combination👁
24 months from IPO close, watch sponsor $3M fulfillment and AI Biotech $30M interest conversion
Filing effective ASAP post-approval under Rule 415, track depositor uptake Dec 31, 2024 balances
- Dravica Corporation/Offering Progress👁
270 days from effective date, min $30k raise for 12-month runway amid going concern
- 21Shares Cronos ETF/Staking Distributions👁
Quarterly cash from CRO rewards starting post-listing, monitor utilization [●]% and zero-distribution risk
- Voyager Acquisition Corp. II/SPAC IPO👁
Post multiple 2025 drafts, watch pricing effectiveness and target sector hints
- JATT II Acquisition Corp/Redemptions👁
20% cap enforcement in de-SPAC, insider transfers to Sidhu/Fernandez for conviction
Category 1-2 (depositors/401(k)) fill rate vs. subsequent, Nasdaq RBKB reaction
Filing Analyses(6)
13-03-2026
Voyager Acquisition Corp. II, a blank check company (SPAC) formerly known as Explorer Acquisition Corp., filed its S-1 registration statement on March 13, 2026, for registration of securities under the Securities Act of 1933. Prior draft registration statements (DRS and DRS/A) were submitted on January 27, 2025, March 7, 2025, and October 3, 2025. No financial performance data or period comparisons are available in the provided EDGAR filing index.
- ·CIK: 0002052096
- ·SIC: 6770 - BLANK CHECKS
- ·Mailing/Business Address: 131 CONCORD STREET, BROOKLYN NY 11201
- ·Phone: 646-577-1351
- ·State location: NY | State of Inc.: E9
- ·S-1 Acc-no: 0001829126-26-002248 (Size: 4 MB)
- ·CF Office: 05 Real Estate & Construction
13-03-2026
Rhinebeck Bancorp, Inc. filed an S-1 registration statement on March 13, 2026, allowing Rhinebeck Bank 401(k) Plan participants to invest up to 3,298,199 shares of common stock at $10.00 per share (totaling approximately $33M), based on plan assets as of December 31, 2025, in connection with the conversion of Rhinebeck Bancorp, MHC to a fully public stock holding company. The offering is subject to purchase priorities favoring depositors and tax-qualified plans, with Rhinebeck Bancorp common stock (RBKB) already trading on Nasdaq Capital Market. No financial performance metrics or period comparisons are provided in the filing.
- ·Filing effective as soon as practicable after SEC approval; continuous offering under Rule 415 checked.
- ·Purchase priorities: (1) Depositors with >=$100 as of Dec 31, 2024; (2) Tax-qualified plans like 401(k); subsequent depositor categories.
- ·Corporate address: 2 Jefferson Plaza, Poughkeepsie, NY 12601; Phone: (845) 454-8555.
- ·Registrant is a smaller reporting company and non-accelerated filer.
13-03-2026
CSB Financial Inc., a newly formed holding company, is filing an S-1 registration statement for an IPO offering up to 1,265,000 shares of common stock at $10.00 per share (potentially increasing to 1,454,750 shares), linked to the mutual-to-stock conversion of Community Savings Bank, with a minimum of 935,000 shares required to complete the offering generating gross proceeds from $9.35M to $14.55M. Net proceeds are estimated at $7.75M to $12.95M after $1.19M in offering expenses and $410k in selling agent fees. The company plans to contribute 27,500 shares and $100,000 cash to a new charitable foundation upon completion.
- ·Filing date: March 13, 2026; Prospectus date: May ____, 2026.
- ·Subscription offering expires at 5:00 p.m. ET on June ___, 2026; may extend up to 90 days or complete by June ___, 2028.
- ·CSB Financial incorporated February 18, 2026; Community Savings Bank originally chartered 1889, acquired The Home Building and Loan Company in 2014.
- ·One-to-four family residential mortgage loans represent 44.2% of total loans at December 31, 2025.
- ·Funds in subscription/community offering earn 0.15% interest per annum.
13-03-2026
JATT II Acquisition Corp, a Cayman Islands blank check company (SPAC), filed an S-1 registration statement for an initial public offering of 6,000,000 ordinary shares at $10.00 per share, targeting gross proceeds of $60M, with underwriters' over-allotment option for 900,000 shares; unlike typical SPACs, no warrants are offered. Sponsor JATT Ventures II L.P. committed to purchase 300,000 private placement shares for $3M concurrently, while AI Biotechnology LLC indicated non-binding interest in up to $30M of shares post-business combination. Founder shares (1,725,000) were acquired for a nominal $25,000, posing immediate material dilution to public shareholders, and redemption rights are capped at 20% aggregate without consent.
- ·Completion window: 24 months from IPO closing or earlier board-approved date.
- ·IPO shares par value: $0.0001.
- ·Founder share transfers: 150,000 to Dr. Someit Sidhu, 50,000 to Nicholas Fernandez, 25,000 each to independent directors and consultant.
13-03-2026
Dravica Corporation, incorporated on September 29, 2025, in Nevada, is registering 4,000,000 shares of common stock at $0.03 per share in a best-efforts IPO to raise up to $120,000, self-underwritten by its President Szubanski Robert Damian, who owns 100% of the existing 2,000,000 shares. The early-stage company focusing on digital communication tools has generated no revenues and reported a net loss of $12,384 from inception through October 31, 2025, with auditors expressing substantial doubt about its going concern status. It previously raised $8,000 via private placement from its President and requires at least $30,000 from the offering to fund operations for 12 months.
- ·Fiscal year end: October 31
- ·Incorporation date: September 29, 2025
- ·Offering duration: 270 days from effective date or earlier termination
- ·Business address: Virtual office at 3827 S Carson St 505-25, Carson City, NV 89701
- ·Operations conducted primarily in Poland and Germany
13-03-2026
21Shares Cronos ETF filed an S-1 registration statement on March 13, 2026, to register shares for public listing on an exchange, representing a trust holding CRO tokens from the Cronos Ecosystem with integrated staking activities. The staking model targets a Utilization Rate to stake between [●]% and [●]% of CRO holdings (maximum [●]%) while managing liquidity risks, with Figment Inc. as the Staking Services Provider receiving a portion of rewards alongside the Sponsor and CRO Custodian (aggregate [●]%). The Trust plans quarterly cash distributions of staking rewards funded by selling liquid CRO, though amounts are uncertain and may be zero if rewards are insufficient.
- ·Former company name: Jura Pentium Trust (name change date: March 18, 2025)
- ·Fiscal year end: December 31
- ·SEC file number: 333-294279
- ·Initial Seed Creation Investor (21Shares US LLC) to purchase [●] initial seed creation baskets at $[●] per Share, proceeds approximately $[●]
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 6 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)